Results of a small study suggest similar pathophysiology of cognitive dysfunction and neuropathic pain in patients with long COVID. Among patients with long COVID, approximately 20% were found to have ...
We plan to share the results of the trial with the scientific community in the near future in the hopes of contributing to the understanding of AD pathophysiology and advancing effective therapeutics ...
Derm-Biome CEO Gordon Eberwein: “We very much look forward to adding Dr. Jerry Tan and his vast knowledge to our team. The acne market is changing, as consumers seek safer and more natural topical ...
Type 2 diabetes (T2D) and obesity (OB) are associated with chronic low-grade inflammation and increased fracture risk. In vitro studies showed that inflammation induces bone erosion and inhibits bone ...
Though Piper is bullish on the transformative potential of the OX2R agonists in sleep/wake, it still envisions a sizable role for oxybate products, particularly in narcolepsy type 2 and idiopathic ...
Preventive therapies targeting calcitonin gene-related peptide (CGRP)—ie, monoclonal anti-CGRP or anti-CGRP receptor antibodies, which are injected subcutaneously or intravenously, and gepants, which ...
The introduction of our first bispecific candidate for inflammatory diseases, CDX-622, builds on our leadership in mast cell biology,” said Anthony Marucci, Co-founder, President and Chief Executive ...